1 |
Liu LL, Skribek M, Harmenberg U, Gerling M. Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature. J Immunother Cancer 2023;11. [PMID: 36878533 DOI: 10.1136/jitc-2022-005841] [Reference Citation Analysis]
|
2 |
Said NS, Degu A. Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya. Cancer Med 2023. [PMID: 36708066 DOI: 10.1002/cam4.5658] [Reference Citation Analysis]
|
3 |
Malvezzi M, Santucci C, Boffetta P, Collatuzzo G, Levi F, La Vecchia C, Negri E. EUROPEAN CANCER MORTALITY PREDICTIONS FOR THE YEAR 2023 WITH FOCUS ON LUNG CANCER. Ann Oncol 2023:S0923-7534(23)00048-0. [PMID: 36882139 DOI: 10.1016/j.annonc.2023.01.010] [Reference Citation Analysis]
|
4 |
Liu LL, Skribek M, Harmenberg U, Gerling M. Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: Systematic review of the literature.. [DOI: 10.1101/2022.07.28.22278028] [Reference Citation Analysis]
|
5 |
Zhu RY, Chen H, Gao YJ, Pan ZH, Wang JY. Effects of psychological nursing care on anxiety and depression in perioperative patients with lung cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e29914. [PMID: 35866819 DOI: 10.1097/MD.0000000000029914] [Reference Citation Analysis]
|